|
Zhou, Ming; Lucas, David A; Chan, King C et al. (2004) An investigation into the human serum ""interactome"". Electrophoresis 25:1289-98
|
|
Ornstein, David K; Rayford, Walter; Fusaro, Vincent A et al. (2004) Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol 172:1302-5
|
|
Interewicz, B; Olszewski, W L; Leak, L V et al. (2004) Profiling of normal human leg lymph proteins using the 2-D electrophoresis and SELDI-TOF mass spectrophotometry approach. Lymphology 37:65-72
|
|
Petricoin, Emanuel F; Ornstein, David K; Liotta, Lance A (2004) Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. Urol Oncol 22:322-8
|
|
Liotta, Lance A; Kohn, Elise (2004) Anoikis: cancer and the homeless cell. Nature 430:973-4
|
|
Krieg, Rene C; Knuechel, Ruth; Schiffmann, Elliot et al. (2004) Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation. Proteomics 4:2789-95
|
|
Johann Jr, Donald J; McGuigan, Michael D; Patel, Amit R et al. (2004) Clinical proteomics and biomarker discovery. Ann N Y Acad Sci 1022:295-305
|
|
Espina, Virginia; Woodhouse, Elisa C; Wulfkuhle, Julia et al. (2004) Protein microarray detection strategies: focus on direct detection technologies. J Immunol Methods 290:121-33
|
|
Geho, David H; Lahar, Nicholas; Ferrari, Mauro et al. (2004) Opportunities for nanotechnology-based innovation in tissue proteomics. Biomed Microdevices 6:231-9
|
|
Petricoin, Emanuel F; Fishman, David A; Conrads, Thomas P et al. (2004) Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics. Proteomics 4:2357-60
|
Showing the most recent 10 out of 31 publications
